Positron Emission Tomography for the Discovery of New Drugs in Psychiatry - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue ACS Chemical Neuroscience Année : 2023

Positron Emission Tomography for the Discovery of New Drugs in Psychiatry

Résumé

The arsenal of drugs for psychiatry has been difficult to renew for several decades. Many failures in therapeutic trials can be explained by poorly evaluated pharmacological properties, in terms of brain passage, target binding, and functional modulation. Positron emission tomography can provide pharmacokinetic and pharmacodynamic data that will help to better select candidate molecules for larger-scale clinical trials.

Domaines

Imagerie
Fichier non déposé

Dates et versions

hal-04528842 , version 1 (02-04-2024)

Identifiants

Citer

Luc Zimmer. Positron Emission Tomography for the Discovery of New Drugs in Psychiatry. ACS Chemical Neuroscience, 2023, 14 (4), pp.524-526. ⟨10.1021/acschemneuro.3c00036⟩. ⟨hal-04528842⟩
6 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More